collaboration
NanoDx, Skywater Technology Partner on Nanoscale Sensors
The firms said NanoDx plans to pursue an FDA EUA for a rapid point-of-care COVID-19 test and is partnering with SkyWater to ramp up production of the product.
MD Anderson, BostonGene Ink Collaboration to Develop Cancer Diagnostics
The partners will validate therapeutically actionable cancer biomarker targets and develop multiple tests from this research.
Scienion, Pictor Developing High-Throughput SARS-CoV-2 Antibody Testing System
The companies are creating a platform that will test for both anti-nucleocapsid and anti-spike antibodies in the same reaction.
Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx
Genomenon will apply its AI-driven technology to develop a "genomic landscape" for specific conditions and combine those data with therapy and trial information.
Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients
The study, called CORRECT-MRD II, is expected to enroll approximately 750 patients at 35 study sites in the US and Canada.